Syncom Formulations (India) Limited (BOM:524470)
India · Delayed Price · Currency is INR 13.19
+0.09 (0.69%)
At close: Jul 27, 2026
BOM:524470 Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 4,892 | 4,892 | 4,650 | 2,634 | 2,243 | 2,197 |
Revenue Growth | 5.20% | 5.20% | 76.55% | 17.45% | 2.09% | -10.27% |
Gross Profit Gross Profit Growth | 2,049 | 2,049 | 1,562 | 1,054 | 818.18 | 787.32 |
Operating Income Operating Income Growth | 708.99 | 708.99 | 487.29 | 247.51 | 149.49 | 159.87 |
Net Income Net Income Growth | 764.38 | 764.38 | 494.35 | 253.14 | 200.71 | 197.9 |
Earnings Per Share EPS Growth | 0.81 | 0.81 | 0.53 | 0.27 | 0.22 | 0.23 |
EPS Growth | 54.02% | 54.02% | 95.28% | 24.58% | -4.63% | -37.14% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceuticals Drugs & Formulations Pharmaceuticals Drugs & Formulations Growth | 5,157 | 5,157 | 4,703 | 2,622 | 2,100 | 2,195 |
Trading of Commodities Trading of Commodities Growth | 11 | 11 | 82.58 | 107.13 | 255.24 | 94.23 |
Renting of Property Renting of Property Growth | 36.77 | 36.77 | 39.15 | 40.19 | 33.53 | 26.86 |
Total Total Growth | 5,205 | 5,205 | 4,824 | 2,769 | 2,389 | 2,317 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,129 | 1,129 | 899.28 | 1,316 | 708.97 | 403.33 |
Total Debt Total Debt Growth | 14.74 | 14.74 | 45.84 | 724.87 | 831.82 | 577.91 |
Net Cash (Debt) Net Cash Growth | 1,114 | 1,114 | 853.45 | 590.78 | -122.85 | -174.58 |
Net Cash Growth | 30.51% | 30.51% | 44.46% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.18 | 1.18 | 0.91 | 0.63 | -0.13 | -0.20 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 580.79 | 580.79 | 234.36 | -59.58 | 105.29 | 163.29 |
Capital Expenditures CapEx Growth | -116.7 | -116.7 | -99.59 | -81.36 | -206.35 | -113.13 |
Free Cash Flow Free Cash Flow Growth | 464.09 | 464.09 | 134.77 | -140.95 | -101.05 | 50.16 |
Free Cash Flow Growth | 244.36% | 244.36% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 41.89% | 41.89% | 33.58% | 40.03% | 36.48% | 35.84% |
Operating Margin | 14.49% | 14.49% | 10.48% | 9.40% | 6.67% | 7.28% |
Pretax Margin | 20.67% | 20.67% | 14.09% | 12.89% | 11.85% | 11.92% |
Profit Margin | 15.63% | 15.63% | 10.63% | 9.61% | 8.95% | 9.01% |
FCF Margin | 9.49% | 9.49% | 2.90% | -5.35% | -4.51% | 2.28% |
| Fiscal Year | FY 2022 |
|---|---|
| Period Ending | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.030 |
Dividend Per Share Growth | - |
Dividend Yield | 0.28% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 16.28 | 12.67 | 31.28 | 41.52 | 27.63 | 46.33 |
P/FCF Ratio | 26.72 | 20.86 | 114.74 | - | - | 182.77 |
PS Ratio | 2.53 | 1.98 | 3.33 | 3.99 | 2.47 | 4.17 |